Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotypes 1-4 and 6 in Myanmar: Real-world experience

2017 ◽  
Vol 24 (11) ◽  
pp. 927-935 ◽  
Author(s):  
N. K. T. Hlaing ◽  
R. A. Mitrani ◽  
S. T. Aung ◽  
W. W. Phyo ◽  
M. Serper ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Real World ◽  
Safety And Efficacy ◽  
Direct Acting Antiviral ◽  
Virus Genotypes ◽  
Hepatitis C Virus Genotypes ◽  
Direct Acting

Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection

2019 ◽  
Vol 34 (9) ◽  
pp. 1597-1603 ◽  
Author(s):  
Lai Wei ◽  
Hiromitsu Kumada ◽  
Ponni V Perumalswami ◽  
Tawesak Tanwandee ◽  
Wendy Cheng ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Safety And Efficacy ◽  
Virus Genotypes ◽  
Hepatitis C Virus Genotypes

scholarly journals Effectiveness of sofosbuvir based direct-acting antiviral regimens for chronic hepatitis C virus genotype 6 patients: Real-world experience in Vietnam

PLoS ONE ◽  
2020 ◽  
Vol 15 (5) ◽  
pp. e0233446
Author(s):  
Dung Thanh Nguyen ◽  
Thanh Thi Thanh Tran ◽  
Ngoc My Nghiem ◽  
Phuong Thanh Le ◽  
Quang Minh Vo ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Real World ◽  
Virus Genotype ◽  
Direct Acting Antiviral ◽  
Chronic Hepatitis C Virus ◽  
Direct Acting
Sign in / Sign up

Export Citation Format

Share Document